HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guo Xian Long Selected Research

Nasopharyngeal Carcinoma

8/2014Single-arm, multi-centre phase II study of lobaplatin combined with docetaxel for recurrent and metastatic nasopharyngeal carcinoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guo Xian Long Research Topics

Disease

1Nasopharyngeal Carcinoma
08/2014

Drug/Important Bio-Agent (IBA)

1lobaplatinIBA
08/2014
1Docetaxel (Taxotere)FDA Link
08/2014